This study found that both new and old formulas of DCP for treating alopecia areata resulted in similar hairregrowth, but tolerance was significantly better with DCP in isopropanol.
In this study, topical minoxidil was found to be an effective, safe, and easy treatment for individuals with alopecia areata affecting 25–99% of the scalp, but less effective for total scalp hair loss.
62 citations
,
April 2002 in “Journal of the American Academy of Dermatology”
In this study, sulfasalazine treatment resulted in cosmeticallyacceptablehairregrowth in 23% of patients with severe alopecia areata in whom a response could be determined.
78 citations
,
April 1984 in “Archives of Dermatology”
This study found that 1% minoxidil topical solution led to terminal hairregrowth in some patients with alopecia areata, though it was only cosmeticallyacceptable in less than half of those cases.
The user has been taking finasteride for 1.5 years without seeing improvement in hairregrowth. Suggestions include adding minoxidil or switching to dutasteride, with concerns about side effects.
Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.
The user is experiencing increased hair thinning and shedding despite using oral dutasteride, oral minoxidil, topical dutasteride, and ketoconazole shampoo. Many recommend considering a hair transplant or embracing baldness, as current treatments seem ineffective.
PP405 shows potential for hair growth, with 31% of advanced balding men experiencing over 20% increase in hair density in 8 weeks. However, skepticism persists due to selective data presentation and lack of long-term results, with comparisons to treatments like minoxidil and finasteride.
The user is frustrated with hair loss, having switched from topical minoxidil and finasteride to dutasteride and oral minoxidil without seeing improvements. They are considering a hair transplant and are advised to continue the current treatment and explore therapy or lifestyle changes.
How does bimatoprost compare to minoxidil for hairregrowth?Minoxidil is FDA-approved for scalp hair loss and backed by decades of large trials; bimatoprost is approved only for eyelashes, and the published scalp evidence is limited to small short studies, so on the scalp it is off-label and experimental.
Got small bald patches they say are from stress? PP405 sprays could help bring them back to life.PP405 is an experimental topical gel from Pelage Pharmaceuticals that inhibits the mitochondrial pyruvate carrier; its registered Phase 2 trial (NCT06393452) tested it once daily in 78 adults with pattern hair loss, for safety and tolerability. It is not approved, not for sale, and has not been studied in alopecia areata or stress-related shedding.
Can I use hair loss treatments (finasteride, minoxidil) after scalp micropigmentation?About half of clinics say finasteride can continue through scalp micropigmentation, and about half ask clients to pause topical minoxidil during the sessions and for roughly 30 days afterwards. That pause is clinic aftercare convention, not a label instruction - ask your prescriber first, because stopping minoxidil usually causes shedding.